Reduced glutathione in a highly soluble, amorphous solid form, and process for the preparation thereof
US2019231810A1
Low polydispersity, low molecular weight biotechnological chondroitin sulfate with anti-inflammatory and antiarthritis activity and use thereof in the prevention of osteoarthritis
MX2019007072A
Process for the purification of lipopolypeptide antibiotics.
US2019010182A1
Salt of (ss)-adenosyl methionine with inositol hexaphosphate, and process for the preparation thereof
EP3270902A1
Solid forms of menaquinols
AU2014345562A1
Crystalline forms of S-acetyl glutathione, their preparations and uses in pharmaceutical and nutraceutical formulations
EP2976065A1
Sterile s-adenosyl methionine with a high content of active isomer for injectable solutions, and procedure for obtaining it
ITMI20131906A1
ORAL SOLID COMPOSITIONS WITH SLOW RELEASE
AU2013265350A1
Low -molecular -weight biotechnological chondroitin 6 - sulphate for prevention of osteoarthritis
ITMI20130117A1
COMPOSITIONS INCLUDING CONDROITIN SULFATE, PROTEOLITHIC ENZYMES AND COMPOUNDS OF SULFIDRYLATES TO IMPROVE THE BIOAVAILABILITY OF CONDROITIN SULFATE
IL224086A
Composition comprising shellac and/or a salt thereof and sodium starch glycolate
CA2843794A1
Formulations containing saccharomyces boulardii and superoxide dismutase (sod) to control obesity
GEP201606591B
Biotechnological sulphated chondroitin sulphate at position 4 or 6 on the same polysaccharide chain, and process for the preparation thereof
GEP20156363B
Composition comprising shellac and/or a salt thereof and sodium starch glycolate
UA111066C2
Composition containing shellack and/or the salt thereof and sodium starch glycolate
GEP201706720B
Biotechnological production of chondroitin
GEP20166465B
Chondroitin sulphate of sharp-type and method for preparation thereof
UA110717C2
Analog shark hondroyitynsulfatu and how to obtain
EP2189154A1
Effervescent tablets and mouth-soluble granulates of S-adenosyl methionine and process for the preparation thereof
EP2095828A1
Use of S-adenosylmethionine (SAM) and superoxide dismutase (SOD) for the preparation of medicaments for the treatment of Alzeimer's disease
